{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:02:18Z","timestamp":1780574538845,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.vaccine.2010.07.086","type":"journal-article","created":{"date-parts":[[2010,8,7]],"date-time":"2010-08-07T08:38:54Z","timestamp":1281170334000},"page":"6945-6950","source":"Crossref","is-referenced-by-count":30,"title":["WHO Informal Consultation on standardization and evaluation of BCG vaccines Geneva, Switzerland 22\u201323 September 2009"],"prefix":"10.1016","volume":"28","author":[{"given":"Mei M.","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Southern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Na","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Knezevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21\u201322","key":"10.1016\/j.vaccine.2010.07.086_bib0005","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1016\/j.vaccine.2004.01.050","article-title":"Report on a WHO consultation on the characterisation of BCG strains, Imperial College, London 15\u201316 December 2003","volume":"22","author":"Corbel","year":"2004","journal-title":"Vaccine"},{"issue":"50","key":"10.1016\/j.vaccine.2010.07.086_bib0010","doi-asserted-by":"crossref","first-page":"5700","DOI":"10.1016\/j.vaccine.2005.07.048","article-title":"Report on a WHO consultation on the characterisation of BCG vaccines, WHO, Geneva, Switzerland 8\u20139 December 2004","volume":"23","author":"Ho","year":"2005","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.vaccine.2010.07.086_bib0015","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1016\/j.vaccine.2006.03.014","article-title":"WHO discussion on the improvement of the quality control of BCG vaccines. Pasteur Institute, Paris, France, 7 June 2005","volume":"24","author":"Knezevic","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.07.086_bib0020","unstructured":"WHO Expert Committee on Biological Standardization. Requirements for freeze-dried BCG vaccine. World Health Organization Technical Report Series 1987;745:60\u201392."},{"issue":"33","key":"10.1016\/j.vaccine.2010.07.086_bib0025","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1016\/j.vaccine.2009.05.048","article-title":"Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2010.07.086_bib0030","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1128\/IAI.73.2.1196-1203.2005","article-title":"Long-term protection against tuberculosis following vaccination with a severely attenuated double lysine and pantothenate auxotroph of Mycobacterium tuberculosis","volume":"73","author":"Sambandamurthy","year":"2005","journal-title":"Infect Immun"},{"issue":"37\u201339","key":"10.1016\/j.vaccine.2010.07.086_bib0035","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1016\/j.vaccine.2006.05.097","article-title":"Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis","volume":"24","author":"Sambandamurthy","year":"2006","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2010.07.086_bib0040","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1016\/j.vaccine.2006.03.017","article-title":"The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs","volume":"24","author":"Martin","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2010.07.086_bib0045","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1517\/14712598.8.2.201","article-title":"Live tuberculosis vaccines based on phoP mutants: a step towards clinical trials","volume":"8","author":"Asensio","year":"2008","journal-title":"Expert Opin Biol Ther"},{"issue":"9","key":"10.1016\/j.vaccine.2010.07.086_bib0050","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette\u2013Guerin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.vaccine.2010.07.086_bib0055","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1086\/592450","article-title":"A new recombinant bacille Calmette\u2013Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers","volume":"198","author":"Hoft","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.07.086_bib0060","unstructured":"European Pharmacopoeia. Strasbourg, Cedex, France: Directorate for the Quality of Medicines of the Council of Europe (EDQM), BCG vaccine, freeze-dried. 01\/2008:2008;0163. p. 759\u201361."},{"issue":"2","key":"10.1016\/j.vaccine.2010.07.086_bib0065","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1128\/IAI.00685-08","article-title":"Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ure C hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosis","volume":"77","author":"Tchilian","year":"2009","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2010.07.086_bib0070","doi-asserted-by":"crossref","first-page":"e5264","DOI":"10.1371\/journal.pone.0005264","article-title":"MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques","volume":"4","author":"Verreck","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2010.07.086_bib0075","article-title":"Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimen","author":"Skeiky","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2010.07.086_bib0080","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1086\/590185","article-title":"Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa","volume":"198","author":"Hawkridge","year":"2008","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2010.07.086_bib0085","doi-asserted-by":"crossref","first-page":"e5934","DOI":"10.1371\/journal.pone.0005934","article-title":"Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A","volume":"4","author":"Whelan","year":"2009","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.vaccine.2010.07.086_bib0090","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1128\/CVI.00067-09","article-title":"Development of a murine mycobacterial growth inhibition assay for evaluating vaccines against Mycobacterium tuberculosis","volume":"16","author":"Parra","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"13","key":"10.1016\/j.vaccine.2010.07.086_bib0095","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1073\/pnas.0700869104","article-title":"Genome plasticity of BCG and impact on vaccine efficacy","volume":"104","author":"Brosch","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.vaccine.2010.07.086_bib0100","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.vaccine.2009.01.034","article-title":"Whole genome sequence analysis of Mycobacterium bovis bacillus Calmette\u2013Guerin (BCG) Tokyo 172: a comparative study of BCG vaccine substrains","volume":"27","author":"Seki","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2010.07.086_bib0105","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/1097-0061(20000630)17:2<111::AID-YEA17>3.0.CO;2-G","article-title":"Comparative genomics uncovers large tandem chromosomal duplications in Mycobacterium bovis BCG Pasteur","volume":"17","author":"Brosch","year":"2000","journal-title":"Yeast"},{"issue":"23","key":"10.1016\/j.vaccine.2010.07.086_bib0110","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1016\/j.vaccine.2006.03.055","article-title":"Identification of two subpopulations of Bacillus Calmette\u2013Guerin (BCG) Tokyo172 substrain with different RD16 regions","volume":"24","author":"Honda","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2010.07.086_bib0115","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biologicals.2006.07.005","article-title":"Quantification of two variant strains contained in freeze-dried Japanese BCG vaccine preparation by real-time PCR","volume":"35","author":"Shibayama","year":"2007","journal-title":"Biologicals"},{"issue":"15\u201316","key":"10.1016\/j.vaccine.2010.07.086_bib0120","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/S0264-410X(00)00369-8","article-title":"Identification of substrains of BCG vaccine using multiplex PCR","volume":"19","author":"Bedwell","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.07.086_bib0125","unstructured":"Markey K, Ho MM, Choudhury B, Seki M, Ju L, Castello-Branco LR, et al. Report of an international collaborative study to evaluate the suitability of multiplex PCR as an identity assay for different sub-strains of BCG vaccine, submitted for publication. (GENERIC) Ref Type: Generic."},{"issue":"27\u201330","key":"10.1016\/j.vaccine.2010.07.086_bib0130","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1016\/S0264-410X(03)00484-5","article-title":"The in vitro evolution of BCG vaccines","volume":"21","author":"Mostowy","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.07.086_bib0135","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/1471-2164-9-413","article-title":"Novel genome polymorphisms in BCG vaccine strains and impact on efficacy","volume":"9","author":"Leung","year":"2008","journal-title":"BMC Genomics"},{"issue":"5","key":"10.1016\/j.vaccine.2010.07.086_bib0140","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1590\/S0074-02762005000500002","article-title":"BCG Moreau Rio de Janeiro: an oral vaccine against tuberculosis\u2014review","volume":"100","author":"Benevolo-de-Andrade","year":"2005","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2010.07.086_bib0145","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-8518-4-4","article-title":"Modulation of humoral immune response to oral BCG vaccination by Mycobacterium bovis BCG Moreau Rio de Janeiro (RDJ) in healthy adults","volume":"4","author":"Monteiro-Maia","year":"2006","journal-title":"J Immune Based Ther Vaccines"},{"issue":"6757","key":"10.1016\/j.vaccine.2010.07.086_bib0150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/47042","article-title":"Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice","volume":"402","author":"Cox","year":"1999","journal-title":"Nature"},{"issue":"7004","key":"10.1016\/j.vaccine.2010.07.086_bib0155","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nature02837","article-title":"A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response","volume":"431","author":"Reed","year":"2004","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.vaccine.2010.07.086_bib0160","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1128\/JB.187.7.2267-2277.2005","article-title":"Transposon mutagenesis of Mb0100 at the ppe1-nrp locus in Mycobacterium bovis disrupts phthiocerol dimycocerosate (PDIM) and glycosylphenol-PDIM biosynthesis, producing an avirulent strain with vaccine properties at least equal to those of M. bovis BCG","volume":"187","author":"Hotter","year":"2005","journal-title":"J Bacteriol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.07.086_bib0165","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.tube.2008.12.001","article-title":"Phenotypic differences between BCG vaccines at the proteome level","volume":"89","author":"Rodriguez-Alvarez","year":"2009","journal-title":"Tuberculosis (Edinb)"},{"issue":"3","key":"10.1016\/j.vaccine.2010.07.086_bib0170","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.vaccine.2008.10.058","article-title":"Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosis","volume":"27","author":"Horwitz","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2010.07.086_bib0175","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1574-695X.2009.00559.x","article-title":"Comparable studies of immunostimulating activities in vitro among Mycobacterium bovis bacillus Calmette\u2013Guerin (BCG) substrains","volume":"56","author":"Hayashi","year":"2009","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.07.086_bib0180","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1128\/IAI.74.3.1718-1724.2006","article-title":"Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB\/c model of progressive pulmonary tuberculosis","volume":"74","author":"Castillo-Rodal","year":"2006","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2010.07.086_bib0185","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.biologicals.2008.05.001","article-title":"Development and validation of an ATP method for rapid estimation of viable units in lyophilised BCG Danish 1331 vaccine","volume":"36","author":"Jensen","year":"2008","journal-title":"Biologicals"},{"issue":"36","key":"10.1016\/j.vaccine.2010.07.086_bib0190","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1016\/j.vaccine.2008.06.026","article-title":"Report of an international collaborative study to establish the suitability of using modified ATP assay for viable count of BCG vaccine","volume":"26","author":"Ho","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.07.086_bib0195","unstructured":"Ho MM, Markey K, Rigsby P, Hockley J, Corbel MJ. Report of an International collaborative study to establish the First WHO Reference Reagents for BCG vaccine of three different sub-strains, submitted for publication. (GENERIC) Ref Type: Generic."},{"issue":"9517","key":"10.1016\/j.vaccine.2010.07.086_bib0200","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculosis meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.07.086_bib0205","doi-asserted-by":"crossref","first-page":"a2052","DOI":"10.1136\/bmj.a2052","article-title":"Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial","volume":"337","author":"Hawkridge","year":"2008","journal-title":"BMJ"},{"issue":"9493","key":"10.1016\/j.vaccine.2010.07.086_bib0210","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial","volume":"366","author":"Rodrigues","year":"2005","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2010.07.086_bib0215","first-page":"344","article-title":"Comparison of the prevalence of tuberculosis infection in BCG vaccinated versus nonvaccinated school age children","volume":"44","author":"Pulickal","year":"2007","journal-title":"Indian Pediatr"},{"issue":"44","key":"10.1016\/j.vaccine.2010.07.086_bib0220","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1016\/j.vaccine.2009.08.031","article-title":"BCG vaccination reduces risk of infection with Mycobacterium tuberculosis as detected by gamma interferon release assay","volume":"27","author":"Eisenhut","year":"2009","journal-title":"Vaccine"},{"issue":"40","key":"10.1016\/j.vaccine.2010.07.086_bib0225","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1016\/j.vaccine.2009.06.103","article-title":"Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response","volume":"27","author":"Kagina","year":"2009","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2010.07.086_bib0230","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1086\/597304","article-title":"HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette\u2013Guerin vaccine","volume":"199","author":"Mansoor","year":"2009","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2010.07.086_bib0235","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vaccine.2006.07.020","article-title":"The risk of disseminated Bacille Calmette\u2013Guerin (BCG) disease in HIV-infected children","volume":"25","author":"Hesseling","year":"2007","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10011084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10011084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,9]],"date-time":"2018-12-09T00:24:56Z","timestamp":1544315096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10011084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":47,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0264410X10011084"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.07.086","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}